Page 4 - Media Outside News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Summing up, the lawyer for the shareholders said that the billionaire was not above the law while mr musk�*s attorney said his client was not a tweeting monster. james clayton has been following the case. elon musk seemed nervous after he'd given evidence. how did i do he asked the media outside. and, he had asked the media outside. and, he had a lot to lose, potentially billions,. in terms of an individual tweets, this tweet had already been extremely costly. in august 2018, he tweeted out that he had funding secured to take tesla private. that would effectively mean buying out tesla shareh...

Democrats in blame game over Oregon congressional loss, Local News, Portland local News, Breaking News alerts for Portland city.

Forward so far. there is more than 2500 people who entered, and the fbi is still looking for 350 people on that list who are still wanted for attacking law enforcement or attacking people of the media outside. so this is gonna go on for a very, very long time ahead. i think a lot of these individuals are going to be able to beat these charges because there is a mountain of evidence against them. and a lot of these individuals, when they go in front of the jury, the jew -- were going forward, we are going to see this case turnout. but this is a very slow process for the justice department becau...

These people who have not yet been arrested yet. but what has happened in some cases, especially in the case of ray epps, the most famous one, where his image was removed from the website, and there are a lot of explanations for that. one of them being that that's not necessarily -- he doesn't necessarily cross those lines that prosecutors have set. so there were thousands of people unlawfully on the grounds of the capitol. they're not going to prosecute all of those people. who they are going to prosecute is people who actually entered into the building, were engaged in violence against eithe...

- Aducanumab collaboration to convert from Eisai sharing of global profits and losses to a global royalty arrangement, effective January 1, 2023.- Lecanemab collaboration to continue unchanged globally-